These findings unveil a lncRNA-mediated mechanism contributing to ccRCC metastasis and implicate that targeting MILIP represents a novel avenue for the treatment of late-stage ccRCC. This evidence concerns the gene MILIP and nonpapillary renal cell carcinoma.